ArticleBMC cancer2021

Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach.

Jung Won Chun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.